These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.). Bartlett MS; Fishman JA; Durkin MM; Queener SF; Smith JW Exp Parasitol; 1990 Jan; 70(1):100-6. PubMed ID: 2295322 [TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. Cirioni O; Giacometti A; Barchiesi F; Fortuna M; Scalise G J Antimicrob Chemother; 1999 Nov; 44(5):653-9. PubMed ID: 10552982 [TBL] [Abstract][Full Text] [Related]
7. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals. Boylan CJ; Current WL Infect Immun; 1992 Apr; 60(4):1589-97. PubMed ID: 1548080 [TBL] [Abstract][Full Text] [Related]
8. Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model. Fishman JA; Queener SF; Roth RS; Bartlett MS Antimicrob Agents Chemother; 1993 Jul; 37(7):1543-6. PubMed ID: 8395791 [TBL] [Abstract][Full Text] [Related]
9. Inoculated mouse model of Pneumocystis carinii pneumonia. Bartlett MS; Queener SF; Durkin MM; Shaw MM; Smith JW J Protozool; 1991; 38(6):130S-131S. PubMed ID: 1818136 [TBL] [Abstract][Full Text] [Related]
10. Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. Bartlett MS; Current WL; Goheen MP; Boylan CJ; Lee CH; Shaw MM; Queener SF; Smith JW Antimicrob Agents Chemother; 1996 Aug; 40(8):1811-6. PubMed ID: 8843286 [TBL] [Abstract][Full Text] [Related]
11. Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection. Powles MA; McFadden DC; Pittarelli LA; Schmatz DM Infect Immun; 1992 Apr; 60(4):1397-400. PubMed ID: 1548065 [TBL] [Abstract][Full Text] [Related]
12. Pneumocystis carinii pneumonia therapy with 9-deazainosine in rats. Smith JW; Bartlett MS; Queener SF; Durkin MM; Jay MA; Hull MT; Klein RS; Marr JJ Diagn Microbiol Infect Dis; 1987 Jun; 7(2):113-8. PubMed ID: 3498606 [TBL] [Abstract][Full Text] [Related]
13. Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats. D'Antonio RG; Johnson DB; Winn RE; van Dellen AF; Evans ME Antimicrob Agents Chemother; 1986 Feb; 29(2):327-9. PubMed ID: 3487285 [TBL] [Abstract][Full Text] [Related]
14. A rat model for combined Trypanosoma cruzi and Pneumocystis carinii infection. Oz HS; Hughes WT; Varilek GW Microb Pathog; 2000 Dec; 29(6):363-5. PubMed ID: 11095921 [TBL] [Abstract][Full Text] [Related]
15. Genetic diversity of Pneumocystis carinii derived from infected rats, mice, ferrets, and cell cultures. Weinberg GA; Durant PJ J Eukaryot Microbiol; 1994; 41(3):223-8. PubMed ID: 8049685 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of quinupristin-dalfopristin against Pneumocystis carinii. Walzer PD; Ashbaugh A; Collins M; Cushion MT Antimicrob Agents Chemother; 2001 Nov; 45(11):3234-7. PubMed ID: 11600389 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models. Jimenez E; MartÃnez A; Aliouat el M; Caballero J; Dei-Cas E; Gargallo-Viola D Antimicrob Agents Chemother; 2002 Aug; 46(8):2648-50. PubMed ID: 12121948 [TBL] [Abstract][Full Text] [Related]
18. Employment of terbinafine against Pneumocystis carinii infection in rat models. Contini C; Colombo D; Cultrera R; Prini E; Sechi T; Angelici E; Canipari R Br J Dermatol; 1996 Jun; 134 Suppl 46():30-2; discussion 40. PubMed ID: 8763466 [TBL] [Abstract][Full Text] [Related]
19. Establishment of rat model for Pneumocystis carinii infection and cloning of the surface glycoprotein A gene of Pneumocystis carinii. Ouyang LS; Mo QY; Peng HJ; Chen XG; Shen SM Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):427-9. PubMed ID: 12390704 [TBL] [Abstract][Full Text] [Related]
20. The development of Pneumocystis carinii pneumonia in germ-free rats requires immunosuppression and exposure to the Pneumocystis carinii organism. Wolff L; Horch S; Gemsa D Comp Immunol Microbiol Infect Dis; 1993 Jan; 16(1):73-6. PubMed ID: 8440087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]